Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002525666 | SCV000559458 | likely benign | Catecholaminergic polymorphic ventricular tachycardia 1 | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001508199 | SCV000719463 | likely benign | not provided | 2020-09-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000620981 | SCV000737523 | likely benign | Cardiovascular phenotype | 2018-09-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Mayo Clinic Laboratories, |
RCV001508199 | SCV001714188 | uncertain significance | not provided | 2020-02-04 | criteria provided, single submitter | clinical testing | |
Laboratorio de Genetica e Diagnostico Molecular, |
RCV003225729 | SCV003807108 | uncertain significance | Catecholaminergic polymorphic ventricular tachycardia 5 | 2022-06-06 | criteria provided, single submitter | clinical testing | ACMG classification criteria: BP4 supporting |